CTI Biopharma Accelerated Review, And Other News: The Good, Bad, And Ugly Of Biopharma [Seeking Alpha]
CTI BioPharma Corp. (CTIC)
Last cti biopharma corp. earnings: 11/1 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ctibiopharma.com
Company Research
Source: Seeking Alpha
Summary CTI Biopharma received accelerated review tag for pacritinib. Collegium acquires rights to Nucynta. Inovio amended its equity offering. CTI BioPharma Receives Accelerated Review Tag CTI BioPharma (NASDAQ: CTIC Pursuant to this new understanding with the FDA, CTI will amend the PACIFICA pivotal Phase 3 trial protocol. The amendment will let the company carry out the primary analysis of SCR rates on the first 168 patients along with the end of study analysis of Overall Survival and Total Symptom Score. CTI will file its New Drug Application if the study meets its primary endpoint pertaining the SVR rate. The data related to the secondary efficacy endpoints will be used for converting to a regular approval path. Adam R. Craig, M.D., Ph.D., President and Chief Executive Officer of CTI Biopharma said "Pacritinib has now demonstrated clinical benefit in this population in three clinical trials, including two prior randomized Phase 3 studies, so we believe that Pacritinib has the pot
Show less
Read more
Impact Snapshot
Event Time:
CTIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTIC alerts
High impacting CTI BioPharma Corp. news events
Weekly update
A roundup of the hottest topics